# Immune Metabolic Associations in Psoriatic Arthritis

> **NCT03399708** · — · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 60 (actual)

## Conditions studied

- Psoriasis
- Psoriatic Arthritis

## Interventions

- **DRUG:** Apremilast 30mg

## Key facts

- **NCT ID:** NCT03399708
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-12
- **Primary completion:** 2019-10-12
- **Final completion:** 2019-10-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03399708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03399708, "Immune Metabolic Associations in Psoriatic Arthritis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03399708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*